ARCA biopharma provides economic and Gencaro NDA update ARCA biopharma.

Bristow, Chief and President Executive Officer of ARCA. The Company ended the third quarter of 2009 with $10.6 million in cash and cash equivalents. Due to recent actions to lessen operating expenses and corporate liabilities, the business believes that its money and money equivalents are adequate to fund operations, at its current price framework, through at least the first quarter of 2010. The Company is also evaluating additional potential financing resources including equity capital and authorities grant funding.. ARCA biopharma provides economic and Gencaro NDA update ARCA biopharma, Inc.The agency has an average national vacancy rate of ten % and has stated it is short about 500 inspectors. On Thursday, the agriculture secretary resisted phone calls from Democratic senators for a complete ban on downer cattle for human intake. Such cows pose an increased risk of E. Coli, salmonella contamination and mad cow disease since they typically wallow in feces and their immune systems are often weak. Agriculture Secretary Edward T. Schafer instead announced new steps to guarantee the basic safety of the country’s meat supply, including more random inspections of slaughterhouses and immediate audits of the 23 plants supplying meat for federal programs, primarily school lunches.

Additional data on lubiprostone presented at the GASTRO 2009 UEGF/WCOG meeting Sucampo Pharma European countries, Ltd., and Sucampo Pharma Americas, Inc., subsidiaries of Sucampo Pharmaceuticals, Inc.